Ubs Group Ag Invitae Corp Call Options Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $12.2 Million - $16.8 Million	-499,900 Reduced 99.98%	100 $3,000
Q1 2021 May 12, 2021	SELL	$33.06 - $56.93 $2.01 Million - $3.47 Million	-60,900 Reduced 10.86%	500,000 $19.1 Million
Q4 2020 Feb 11, 2021	BUY	$39.09 - $57.4 $2.38 Million - $3.5 Million	60,900 Added 12.18%	560,900 $23.5 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $14.2 Million - $22.3 Million	500,000 New	500,000 $21.7 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.